NCT05347394 A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05331183 Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05329649 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05324410 A Phase 1 Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05312879 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease Status RECRUITING Phase PHASE2/PHASE3
NCT05274269 Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation Status COMPLETED Phase PHASE3
NCT05153317 Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older Status COMPLETED Phase PHASE3
NCT05111145 A Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Participants With Cystic Fibrosis (CF) Status COMPLETED Phase PHASE3
NCT05076149 A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation Status COMPLETED Phase PHASE3
NCT05034952 A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty Status COMPLETED Phase PHASE2
NCT05033080 A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) Status COMPLETED Phase PHASE3
NCT04977336 A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy Status COMPLETED Phase PHASE2
NCT04969224 A Study to Evaluate ELX/TEZ/IVA on Cough and Physical Activity in Participants With Cystic Fibrosis (CF) Status COMPLETED Phase PHASE3
NCT04923464 A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis Status COMPLETED Phase N/A
NCT04786262 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes Status RECRUITING Phase PHASE3
NCT04702360 ELX/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients With at Least One F508del Mutation Status APPROVED_FOR_MARKETING Phase N/A
NCT04599465 A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF) Status COMPLETED Phase PHASE3
NCT04545515 A Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF Genotypes Status COMPLETED Phase PHASE3
NCT04537793 Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years Status COMPLETED Phase PHASE3